News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289,999 Results
Type
Article (14901)
Company Profile (284)
Press Release (274814)
Multimedia
Podcasts (48)
Webinars (8)
Section
Business (85703)
Career Advice (198)
Deals (14382)
Drug Delivery (38)
Drug Development (50772)
Employer Resources (32)
FDA (5961)
Job Trends (5676)
News (152703)
Policy (10607)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1013)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (23823)
ALS (63)
Alzheimer's disease (852)
Antibody-drug conjugate (ADC) (90)
Approvals (5981)
Artificial intelligence (137)
Autoimmune disease (17)
Automation (7)
Bankruptcy (111)
Best Places to Work (4974)
BIOSECURE Act (6)
Biosimilars (42)
Biotechnology (233)
Bladder cancer (49)
Brain cancer (21)
Breast cancer (155)
Cancer (1412)
Cardiovascular disease (118)
Career advice (174)
Career pathing (2)
CAR-T (112)
Cell therapy (318)
Cervical cancer (8)
Clinical research (41258)
Collaboration (546)
Compensation (255)
Complete response letters (13)
COVID-19 (1057)
CRISPR (39)
C-suite (163)
Cystic fibrosis (77)
Data (1448)
Denatured (11)
Depression (29)
Diabetes (134)
Diagnostics (1452)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (83)
Drug pricing (30)
Drug shortages (4)
Duchenne muscular dystrophy (88)
Earnings (30978)
Editorial (19)
Employer branding (4)
Employer resources (30)
Events (50359)
Executive appointments (467)
FDA (6648)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (504)
Gene editing (93)
Generative AI (13)
Gene therapy (240)
GLP-1 (366)
Government (1150)
Grass and pollen (2)
Guidances (21)
Healthcare (7278)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (88)
Indications (19)
Infectious disease (1124)
Inflammatory bowel disease (111)
Inflation Reduction Act (9)
Influenza (20)
Intellectual property (65)
Interviews (18)
IPO (7566)
IRA (12)
Job creations (992)
Job search strategy (165)
Kidney cancer (6)
Labor market (5)
Layoffs (216)
Leadership (3)
Legal (1536)
Liver cancer (31)
Lung cancer (200)
Lymphoma (92)
Machine learning (2)
Management (7)
Manufacturing (134)
MASH (51)
Medical device (2975)
Medtech (2977)
Mergers & acquisitions (7152)
Metabolic disorders (382)
Multiple sclerosis (52)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1245)
NextGen: Class of 2025 (2350)
Non-profit (989)
Northern California (1658)
Now hiring (22)
Obesity (192)
Opinion (107)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (55)
Parkinson's disease (119)
Partnered (10)
Patents (126)
Patient recruitment (73)
Peanut (35)
People (27737)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (14540)
Phase II (19169)
Phase III (12168)
Pipeline (790)
Policy (46)
Postmarket research (868)
Preclinical (6115)
Press Release (31)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (288)
Real estate (1670)
Recruiting (12)
Regulatory (8980)
Reports (16)
Research institute (1031)
Resumes & cover letters (24)
Rett syndrome (4)
RNA editing (4)
RSV (11)
Schizophrenia (57)
Series A (99)
Series B (62)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1454)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (2143)
State (1)
Stomach cancer (4)
Supply chain (22)
Tariffs (5)
The Weekly (36)
United States (13080)
Vaccines (213)
Venture capitalists (31)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (71)
Last 7 days (275)
Last 30 days (1420)
Last 365 days (20012)
2025 (5735)
2024 (21067)
2023 (23055)
2022 (28782)
2021 (30874)
2020 (26384)
2019 (18684)
2018 (13502)
2017 (14547)
2016 (12692)
2015 (15282)
2014 (11112)
2013 (8124)
2012 (8245)
2011 (8394)
2010 (8035)
Location
Africa (169)
Alabama (44)
Alaska (2)
Arizona (62)
Arkansas (5)
Asia (18659)
Australia (3110)
California (3766)
Canada (1115)
China (356)
Colorado (149)
Connecticut (153)
Delaware (98)
Europe (39962)
Florida (453)
Georgia (119)
Hawaii (1)
Idaho (19)
Illinois (233)
India (11)
Indiana (101)
Iowa (1)
Japan (75)
Kansas (63)
Kentucky (5)
Louisiana (4)
Maine (11)
Maryland (473)
Massachusetts (2980)
Michigan (74)
Minnesota (154)
Mississippi (1)
Missouri (36)
Montana (17)
Nebraska (5)
Nevada (19)
New Hampshire (14)
New Jersey (964)
New Mexico (22)
New York (1043)
North Carolina (547)
North Dakota (4)
Northern California (1658)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (720)
Puerto Rico (5)
Rhode Island (21)
South America (247)
South Carolina (5)
Southern California (1454)
Tennessee (26)
Texas (433)
Utah (61)
Virginia (77)
Washington D.C. (30)
Washington State (342)
Wisconsin (15)
289,999 Results for "enterprise therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Enterprise Therapeutics Publishes Preclinical Profile of ETD001, a Novel Inhaled ENaC Blocker
Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, announced the publication of a peer reviewed study in the Journal of Cystic Fibrosis.
June 12, 2024
·
2 min read
Press Releases
QuantHealth Expands Its Leadership Team, Primes its SaaS Platform for Enterprise-Grade Pharmaceutical Partnerships
January 13, 2025
·
4 min read
Press Releases
Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001, a Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
November 19, 2024
·
3 min read
Press Releases
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
February 17, 2025
·
5 min read
Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Enterprise Therapeutics Ltd announced that it has closed a £26 million Series B follow-on financing round, led by Panakes Partners.
January 30, 2024
·
2 min read
Press Releases
Philips expands cloud-based enterprise imaging services to Europe for better access to AI-enabled workflows and innovation
February 28, 2025
·
4 min read
Press Releases
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
March 7, 2025
·
6 min read
Press Releases
Enterprise Therapeutics Granted ‘Rare Pediatric Disease Designation’ in the US for Novel Cystic Fibrosis Investigational Therapy ETD001
September 26, 2024
·
2 min read
Press Releases
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
November 5, 2024
·
3 min read
BioMidwest
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
Ludwig Enterprises, Inc is pleased to announce that its subsidiary Exousia AI is funding a preclinical study on Glioblastoma, an incurable brain cancer.
March 27, 2024
·
3 min read
1 of 29,000
Next
